These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

427 related items for PubMed ID: 18048461

  • 1. Pre-exposure purified vero cell rabies vaccine and concomitant routine childhood vaccinations: 5-year post-vaccination follow-up study of an infant cohort in Vietnam.
    Lang J, Feroldi E, Vien NC.
    J Trop Pediatr; 2009 Feb; 55(1):26-31. PubMed ID: 18048461
    [Abstract] [Full Text] [Related]

  • 2. Randomised feasibility trial of pre-exposure rabies vaccination with DTP-IPV in infants.
    Lang J, Duong GH, Nguyen VG, Le TT, Nguyen CV, Kesmedjian V, Plotkin SA.
    Lancet; 1997 Jun 07; 349(9066):1663-5. PubMed ID: 9186385
    [Abstract] [Full Text] [Related]

  • 3. Booster vaccination at 1 year with a rabies vaccine associated with DTP-IPV in infants living in a rabies endemic country.
    Lang J, Rongrre N, Plotkin S, Hoa DQ, Gioi NV, Le TT.
    J Trop Pediatr; 1999 Jun 07; 45(3):181-3. PubMed ID: 10401204
    [No Abstract] [Full Text] [Related]

  • 4. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM, Rhodes P, Connelly BL, Bi D, Hahn C, Patrick S, Glodé MP, Ehresmann KR, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. kbisgard@cdc.gov.
    Pediatrics; 2005 Aug 07; 116(2):e285-94. PubMed ID: 16061582
    [Abstract] [Full Text] [Related]

  • 5. One-year post-primary antibody persistence and booster immune response to a fully liquid five-component acellular pertussis, diphtheria, tetanus, inactivated poliomyelitis, Haemophilus influenzae type b conjugate vaccine.
    Lin TY, Wang YH, Huang YC, Chiu CH, Lin PY, Chen CJ, Chavand P, Ortiz E.
    Int J Infect Dis; 2007 Nov 07; 11(6):488-95. PubMed ID: 17349809
    [Abstract] [Full Text] [Related]

  • 6. Long-term anti-rabies antibody persistence following intramuscular or low-dose intradermal vaccination of young Vietnamese children.
    Vien NC, Feroldi E, Lang J.
    Trans R Soc Trop Med Hyg; 2008 Mar 07; 102(3):294-6. PubMed ID: 18191971
    [Abstract] [Full Text] [Related]

  • 7. Immunogenicity and safety in adults of a new chromatographically purified Vero-cell rabies vaccine (CPRV): a randomized, double-blind trial with purified Vero-cell rabies vaccine (PVRV).
    Lang J, Cetre JC, Picot N, Lanta M, Briantais P, Vital S, Le Mener V, Lutsch C, Rotivel Y.
    Biologicals; 1998 Dec 07; 26(4):299-308. PubMed ID: 10403033
    [Abstract] [Full Text] [Related]

  • 8. Booster immunization with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate combination vaccine in the second year of life: safety, immunogenicity and persistence of antibody responses.
    Heininger U, DTP-HBV-IPV-059 Study Group, DTP-HBV-IPV-096 Study Group, Sänger R, Jacquet JM, Schuerman L.
    Vaccine; 2007 Jan 22; 25(6):1055-63. PubMed ID: 17049692
    [Abstract] [Full Text] [Related]

  • 9. An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine.
    Langley JM, Predy G, Guasparini R, Law B, Diaz-Mitoma F, Whitstitt P, Tapiero B, Dionne M, Tomovici A, Mills E, Halperin SA.
    Vaccine; 2007 Jan 22; 25(6):1121-5. PubMed ID: 17045366
    [Abstract] [Full Text] [Related]

  • 10. Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.
    Black S, Friedland LR, Ensor K, Weston WM, Howe B, Klein NP.
    Pediatr Infect Dis J; 2008 Apr 22; 27(4):341-6. PubMed ID: 18316985
    [Abstract] [Full Text] [Related]

  • 11. Immunogenicity and safety of a DTaP-IPV//PRP-T vaccine (Pentaxim) booster during the second year of life in Thai children primed with an acellular pertussis combined vaccine.
    Thisyakorn U, Pancharoen C, Chuenkitmongkol S, Ortiz E.
    Southeast Asian J Trop Med Public Health; 2009 Mar 22; 40(2):282-94. PubMed ID: 19323013
    [Abstract] [Full Text] [Related]

  • 12. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine.
    Briggs DJ, Banzhoff A, Nicolay U, Sirikwin S, Dumavibhat B, Tongswas S, Wasi C.
    Bull World Health Organ; 2000 Mar 22; 78(5):693-8. PubMed ID: 10859864
    [Abstract] [Full Text] [Related]

  • 13. Serologic response to rabies pre-exposure vaccination in persons with potential occupational exposure in Singapore.
    Lim PL, Barkham TM.
    Int J Infect Dis; 2010 Jun 22; 14(6):e511-3. PubMed ID: 20018545
    [Abstract] [Full Text] [Related]

  • 14. A fourth dose of DTPa-IPV vaccine given to 4-6 year old children in Italy and Sweden following primary vaccination at 3, 5 and 11-12 months of age.
    Nilsson L, Faldella G, Jacquet JM, Storsaeter J, Silfverdal SA, Ekholm L.
    Scand J Infect Dis; 2005 Jun 22; 37(3):221-9. PubMed ID: 15849057
    [Abstract] [Full Text] [Related]

  • 15. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen.
    Madhusudana SN, Sanjay TV, Mahendra BJ, Suja MS.
    Int J Infect Dis; 2004 May 22; 8(3):175-9. PubMed ID: 15109593
    [Abstract] [Full Text] [Related]

  • 16. Safety and immunogenicity of a DTaP-IPV(Vero) (serum-free) combination vaccine in comparison to DTaP-IPV(Mkc) when administered simultaneously with Haemophilus influenzae type B conjugate vaccine (PRP-T) in children at 2, 3.5, 5 and 16 months of age.
    Pietrzyk JJ, Wysocki J, Pejcz J, Galaj A, Majda-Stanislawska E, Käyhty H, Thierry-Carstensen B, Jensen AM.
    Vaccine; 2008 Sep 26; 26(41):5296-303. PubMed ID: 18675870
    [Abstract] [Full Text] [Related]

  • 17. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
    Zangwill KM, Eriksen E, Lee M, Lee J, Marcy SM, Friedland LR, Weston W, Howe B, Ward JI.
    Pediatrics; 2008 Dec 26; 122(6):e1179-85. PubMed ID: 19047220
    [Abstract] [Full Text] [Related]

  • 18. Immunogenicity and safety of low-dose intradermal rabies vaccination given during an Expanded Programme on immunization session in Viet Nam: results of a comparative randomized trial.
    Lang J, Hoa DQ, Gioi NV, Vien NC, Nguyen CV, Rouyrre N, Forrat R.
    Trans R Soc Trop Med Hyg; 1999 Dec 26; 93(2):208-13. PubMed ID: 10450451
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A comparative study on the safety and immunogenicity of Purified duck embryo vaccine [corrected] (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab).
    Ashwathnarayana DH, Madhusudana SN, Sampath G, Sathpathy DM, Mankeshwar R, Ravish HH, Ullas PT, Behra TR, Sudarshan MK, Gangaboraiah, Shamanna M.
    Vaccine; 2009 Dec 10; 28(1):148-51. PubMed ID: 19818720
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.